Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.320
+0.020 (0.87%)
At close: May 23, 2024, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: May 23, 2024, 7:11 PM EDT

Oramed Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for ORMP.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for ORMP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 000000
Buy 000000
Hold 222221
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a May 20, 2024
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$3$2
Hold Maintains $3$2 -13.79% May 17, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jan 17, 2023
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jan 12, 2023
Aegis Capital
Aegis Capital
Strong Buy
Maintains
$35$30
Strong Buy Maintains $35$30 +1,193.10% May 16, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
1.33M
from 1.34M
Decreased by -1.04%
Revenue Next Year
n/a
from 1.33M
EPS This Year
-0.27
from 0.14
EPS Next Year
-1.10
from -0.27
Year 2019202020212022202320242025
Revenue
2.70M2.71M2.70M2.70M1.34M1.33M-
Revenue Growth
10.37%0.26%-0.26%--50.43%-1.04%-
EPS
-0.82-0.56-0.78-0.940.14-0.27-1.10
EPS Growth
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 2.1M n/a
Avg 1.3M n/a
Low 588,000 n/a

Revenue Growth

Revenue Growth 20242025
High
56.7%
-
Avg
-1.0%
-
Low
-56.1%
-

EPS Forecast

EPS 20242025
High -0.12 -1.13
Avg -0.27 -1.10
Low -0.40 -1.06

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.